|
1
|
Firdous AP, Sindhu ER, Ramnath V and
Kuttan R: Anti-mutagenic and anti-carcinogenic potential of the
carotenoid meso-zeaxanthin. Asian Pac J Cancer Prev. 11:1795–1800.
2010.PubMed/NCBI
|
|
2
|
Patel D, Shukla S and Gupta S: Apigenin
and cancer chemoprevention: Progress potential and promise
(Review). Int J Oncol. 30:233–245. 2007.PubMed/NCBI
|
|
3
|
Weisburger JH: Antimutagens,
anticarcinogens, and effective worldwide cancer prevention. J
Environ Pathol Toxicol Oncol. 18:85–93. 1999.PubMed/NCBI
|
|
4
|
Cordell GA and Araujo OE: Capsaicin:
identification, nomenclature, and pharmacotherapy. Ann
Pharmacother. 27:330–336. 1993.PubMed/NCBI
|
|
5
|
Stavric B: Role of chemopreventers in
human diet. Clin Biochem. 27:319–332. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang SP, Chen JC, Wu CC, et al:
Capsaicin-induced apoptosis in human hepatoma HepG2 cells.
Anticancer Res. 29:165–174. 2009.PubMed/NCBI
|
|
7
|
Kim CS, Park WH, Park JY, et al:
Capsaicin, a spicy component of hot pepper, induces apoptosis by
activation of the peroxisome proliferator-activated receptor gamma
in HT-29 human colon cancer cells. J Med Food. 7:267–273. 2004.
View Article : Google Scholar
|
|
8
|
Chang HC, Chen ST, Chien SY, Kuo SJ, Tsai
HT and Chen DR: Capsaicin may induce breast cancer cell death
through apoptosis-inducing factor involving mitochondrial
dysfunction. Hum Exp Toxicol. 30:1657–1665. 2011. View Article : Google Scholar
|
|
9
|
Baek YM, Hwang HJ, Kim SW, et al: A
comparative proteomic analysis for capsaicin-induced apoptosis
between human hepatocarcinoma (HepG2) and human neuroblastoma
(SK-N-SH) cells. Proteomics. 8:4748–4767. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Enneking WF and Springfield DS:
Osteosarcoma. Orthop Clin North Am. 8:785–803. 1977.
|
|
11
|
Ferguson WS and Goorin AM: Current
treatment of osteosarcoma. Cancer Invest. 19:292–315. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bacci G and Lari S: Adjuvant and
neoadjuvant chemotherapy in osteosarcoma. Chir Organi Mov.
86:253–268. 2001.PubMed/NCBI
|
|
13
|
Biermann JS and Baker LH: The future of
sarcoma treatment. Semin Oncol. 24:592–597. 1997.PubMed/NCBI
|
|
14
|
La Quaglia MP: Osteosarcoma. Specific
tumor management and results. Chest Surg Clin N Am. 8:77–95.
1998.PubMed/NCBI
|
|
15
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Papagelopoulos PJ, Galanis EC, Vlastou C,
et al: Current concepts in the evaluation and treatment of
osteosarcoma. Orthopedics. 23:858–867; quiz 868–869.
2000.PubMed/NCBI
|
|
17
|
Yang C, Ji D, Weinstein EJ, et al: The
kinase Mirk is a potential therapeutic target in osteosarcoma.
Carcinogenesis. 31:552–558. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wieder R: TUNEL assay as a measure of
chemotherapy-induced apoptosis. Methods Mol Med. 111:43–54.
2005.PubMed/NCBI
|
|
19
|
Rohwer F and Azam F: Detection of DNA
damage in prokaryotes by terminal deoxyribonucleotide
transferase-mediated dUTP nick end labeling. Appl Environ
Microbiol. 66:1001–1006. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dhanasekaran DN and Johnson GL: MAPKs:
function, regulation, role in cancer and therapeutic targeting.
Oncogene. 26:3097–3099. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cohen GM: Caspases: the executioners of
apoptosis. Biochem J. 326:1–16. 1997.
|
|
22
|
Kong Q and Lillehei KO: Antioxidant
inhibitors for cancer therapy. Med Hypotheses. 51:405–409. 1998.
View Article : Google Scholar
|
|
23
|
Delling G: Diagnosis of bone tumors. Verh
Dtsch Ges Pathol. 82:121–132. 1998.(In German).
|
|
24
|
Federman N, Bernthal N, Eilber FC and Tap
WD: The multidisciplinary management of osteosarcoma. Curr Treat
Options Oncol. 10:82–93. 2009. View Article : Google Scholar
|
|
25
|
De Luna-Bertos E, Ramos-Torrecillas J,
Garcia-Martinez O, Diaz-Rodriguez L and Ruiz C: Effect of aspirin
on cell growth of human MG-63 osteosarcoma line. Scientific World
Journal. 2012:8342462012.PubMed/NCBI
|
|
26
|
Lin KL, Chi CC, Lu T, et al: Effect of
sertraline on [Ca2+]i and viability of human MG63
osteosarcoma cells. Drug Chem Toxicol. 36:231–240. 2013.
|
|
27
|
Jin S, Shen JN, Wang J, Huang G and Zhou
JG: Oridonin induced apoptosis through Akt and MAPKs signaling
pathways in human osteosarcoma cells. Cancer Biol Ther. 6:261–268.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu CC, Lin JP, Yang JS, et al: Capsaicin
induced cell cycle arrest and apoptosis in human esophagus
epidermoid carcinoma CE 81T/VGH cells through the elevation of
intracellular reactive oxygen species and
Ca2+productions and caspase-3 activation. Mutat Res.
601:71–82. 2006. View Article : Google Scholar
|
|
29
|
Ip SW, Lan SH, Huang AC, et al: Capsaicin
induces apoptosis in SCC-4 human tongue cancer cells through
mitochondria-dependent and -independent pathways. Environ Toxicol.
27:332–341. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang ZH, Wang XH, Wang HP, Hu LQ, Zheng XM
and Li SW: Capsaicin mediates cell death in bladder cancer T24
cells through reactive oxygen species production and mitochondrial
depolarization. Urology. 75:735–741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang R, Humphreys I, Sahu RP, Shi Y and
Srivastava SK: In vitro and in vivo induction of apoptosis by
capsaicin in pancreatic cancer cells is mediated through ROS
generation and mitochondrial death pathway. Apoptosis.
13:1465–1478. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mori A, Lehmann S, O'Kelly J, et al:
Capsaicin, a component of red peppers, inhibits the growth of
androgen-independent, p53 mutant prostate cancer cells. Cancer Res.
66:3222–3229. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bai H, Li H, Zhang W, et al: Inhibition of
chronic pancreatitis and pancreatic intraepithelial neoplasia
(PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice.
Carcinogenesis. 32:1689–1696. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wong RS: Apoptosis in cancer: from
pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yue TL, Ohlstein EH and Ruffolo RR Jr:
Apoptosis: a potential target for discovering novel therapies for
cardiovascular diseases. Curr Opin Chem Biol. 3:474–480. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: a basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Elmore S: Apoptosis: a review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lawen A: Apoptosis - an introduction.
Bioessays. 25:888–896. 2003. View Article : Google Scholar
|
|
39
|
Nagata S: DNA degradation in development
and programmed cell death. Annu Rev Immunol. 23:853–875. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhivotosky B and Orrenius S: Assessment of
apoptosis and necrosis by DNA fragmentation and morphological
criteria. Curr Protoc Cell Biol. Chapter 18(Unit 18):
132001.PubMed/NCBI
|
|
41
|
Negoescu A, Guillermet C, Lorimier P,
Brambilla E and Labat-Moleur F: Importance of DNA fragmentation in
apoptosis with regard to TUNEL specificity. Biomed Pharmacother.
52:252–258. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Seger R and Krebs EG: The MAPK signaling
cascade. FASEB J. 9:726–735. 1995.PubMed/NCBI
|
|
43
|
Raman M, Chen W and Cobb MH: Differential
regulation and properties of MAPKs. Oncogene. 26:3100–3112. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lee S, Lee HS, Baek M, et al: MAPK
signaling is involved in camptothecin-induced cell death. Mol
Cells. 14:348–354. 2002.PubMed/NCBI
|
|
45
|
Ren D, Yang H and Zhang S: Cell death
mediated by MAPK is associated with hydrogen peroxide production in
Arabidopsis. J Biol Chem. 277:559–565. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zohrabian VM, Forzani B, Chau Z, Murali R
and Jhanwar-Uniyal M: Rho/ROCK and MAPK signaling pathways are
involved in glioblastoma cell migration and proliferation.
Anticancer Res. 29:119–123. 2009.PubMed/NCBI
|
|
47
|
Mavria G, Vercoulen Y, Yeo M, et al:
ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell
survival and sprouting during angiogenesis. Cancer Cell. 9:33–44.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Roux PP and Blenis J: ERK and p38
MAPK-activated protein kinases: a family of protein kinases with
diverse biological functions. Microbiol Mol Biol Rev. 68:320–344.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Thornberry NA: The caspase family of
cysteine proteases. Br Med Bull. 53:478–490. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Li X, Su B, Liu R, Wu D and He D:
Tetrandrine induces apoptosis and triggers caspase cascade in human
bladder cancer cells. J Surg Res. 166:e45–e51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fan TJ, Han LH, Cong RS and Liang J:
Caspase family proteases and apoptosis. Acta Biochim Biophys Sin
(Shanghai). 37:719–727. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Denault JB and Salvesen GS: Caspases: keys
in the ignition of cell death. Chem Rev. 102:4489–4500. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Desouza M, Gunning PW and Stehn JR: The
actin cytoskeleton as a sensor and mediator of apoptosis.
Bioarchitecture. 2:75–87. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kannan K and Jain SK: Oxidative stress and
apoptosis. Pathophysiology. 7:153–163. 2000. View Article : Google Scholar
|
|
55
|
Mates JM, Perez-Gomez C and Nunez de
Castro I: Antioxidant enzymes and human diseases. Clin Biochem.
32:595–603. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bostwick DG, Alexander EE, Singh R, et al:
Antioxidant enzyme expression and reactive oxygen species damage in
prostatic intraepithelial neoplasia and cancer. Cancer. 89:123–134.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Circu ML and Aw TY: Reactive oxygen
species, cellular redox systems, and apoptosis. Free Radic Biol
Med. 48:749–762. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Stadtman ER: Role of oxidant species in
aging. Curr Med Chem. 11:1105–1112. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Bechtel W and Bauer G: Catalase protects
tumor cells from apoptosis induction by intercellular ROS
signaling. Anticancer Res. 29:4541–4557. 2009.PubMed/NCBI
|
|
60
|
Inoue M, Sakaguchi N, Isuzugawa K, Tani H
and Ogihara Y: Role of reactive oxygen species in gallic
acid-induced apoptosis. Biol Pharm Bull. 23:1153–1157. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Gao F, Yi J, Yuan JQ, Shi GY and Tang XM:
The cell cycle related apoptotic susceptibility to arsenic trioxide
is associated with the level of reactive oxygen species. Cell Res.
14:81–85. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Cha JH, Choi YJ, Cha SH, Choi CH and Cho
WH: Allicin inhibits cell growth and induces apoptosis in U87MG
human glioblastoma cells through an ERK-dependent pathway. Oncol
Rep. 28:41–48. 2012.PubMed/NCBI
|
